Verdence Capital Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $745K | Sell |
7,202
-275
| -4% | -$24.5K | 0.04% | 354 |
|
|
2026
Q1 | $537K | Buy |
7,477
+61
| +0.8% | +$4.7K | 0.03% | 418 |
|
|
2025
Q4 | $589K | Sell |
7,416
-139
| -2% | -$11K | 0.03% | 382 |
|
|
2025
Q3 | $623K | Sell |
7,555
-307
| -4% | -$21K | 0.04% | 384 |
|
|
2025
Q2 | $542K | Sell |
7,862
-28
| -0.4% | -$1.84K | 0.04% | 388 |
|
|
2025
Q1 | $535K | Buy |
7,890
+89
| +1% | +$5.33K | 0.04% | 367 |
|
|
2024
Q4 | $350K | Sell |
7,801
-294
| -4% | -$16.5K | 0.03% | 457 |
|
|
2024
Q3 | $509K | Sell |
8,095
-57
| -0.7% | -$3.33K | 0.04% | 370 |
|
|
2024
Q2 | $481K | Sell |
8,152
-3,833
| -32% | -$240K | 0.04% | 353 |
|
|
2024
Q1 | $956K | Sell |
11,985
-2,102
| -15% | -$161K | 0.09% | 239 |
|
|
2023
Q4 | $1.11M | Sell |
14,087
-581
| -4% | -$41.4K | 0.11% | 204 |
|
|
2023
Q3 | $1.02M | Buy |
14,668
+2,170
| +17% | +$154K | 0.11% | 204 |
|
|
2023
Q2 | $864K | Buy |
12,498
+328
| +3% | +$23.3K | 0.1% | 218 |
|
|
2023
Q1 | $904K | Sell |
12,170
-1,183
| -9% | -$99.2K | 0.11% | 210 |
|
|
2022
Q4 | $1.24M | Buy |
13,353
+1,060
| +9% | +$102K | 0.15% | 150 |
|
|
2022
Q3 | $1.17M | Buy |
12,293
+1,157
| +10% | +$115K | 0.16% | 147 |
|
|
2022
Q2 | $1.03M | Sell |
11,136
-58
| -0.5% | -$5.66K | 0.13% | 173 |
|
|
2022
Q1 | $1.13M | Buy |
11,194
+1,694
| +18% | +$178K | 0.13% | 177 |
|
|
2021
Q4 | $980K | Sell |
9,500
-889
| -9% | -$82.2K | 0.12% | 182 |
|
|
2021
Q3 | $882K | Buy |
10,389
+102
| +1% | +$8.54K | 0.12% | 189 |
|
|
2021
Q2 | $858K | Buy |
10,287
+420
| +4% | +$34.4K | 0.12% | 182 |
|
|
2021
Q1 | $742K | Sell |
9,867
-158
| -2% | -$11.5K | 0.13% | 170 |
|
|
2020
Q4 | $685K | Buy |
10,025
+683
| +7% | +$44.4K | 0.13% | 163 |
|
|
2020
Q3 | $546K | Sell |
9,342
-112
| -1% | -$6.97K | 0.13% | 181 |
|
|
2020
Q2 | $614K | Buy |
9,454
+1,083
| +13% | +$68.2K | 0.15% | 157 |
|
|
2020
Q1 | $497K | Buy |
8,371
+586
| +8% | +$39.1K | 0.15% | 157 |
|
|
2019
Q4 | $578K | Buy |
7,785
+147
| +2% | +$10.3K | 0.14% | 159 |
|
|
2019
Q3 | $482K | Buy |
7,638
+2,607
| +52% | +$154K | 0.14% | 171 |
|
|
2019
Q2 | $274K | Buy |
5,031
+126
| +3% | +$6.79K | 0.08% | 228 |
|
|
2019
Q1 | $265K | Buy |
4,905
+617
| +14% | +$38.1K | 0.07% | 217 |
|
|
2018
Q4 | $281K | Buy |
4,288
+602
| +16% | +$44.9K | 0.08% | 189 |
|
|
2018
Q3 | $290K | Sell |
3,686
-4,456
| -55% | -$319K | 0.07% | 209 |
|
|
2018
Q2 | $524K | Sell |
8,142
-2,037
| -20% | -$134K | 0.13% | 164 |
|
|
2018
Q1 | $633K | Buy |
10,179
+1,805
| +22% | +$130K | 0.15% | 145 |
|
|
2017
Q4 | $607K | Buy |
+8,374
| New | +$609K | 0.14% | 128 |
|
Other funds holding CVS
CF
HCM
Verdence Capital Advisors's CVS Position: Q2 2026 in Review
Verdence Capital Advisors reduced its CVS Health (CVS) stake by 3.7% in Q2 2026, selling an estimated $24.5K and leaving 7,202 shares worth $745K. The position accounts for 0.04% of the portfolio, ranked #354.
Verdence Capital Advisors first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.24M in Q4 2022. 997 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Verdence Capital Advisors held 7,202 shares of CVS Health worth $745K as of Q2 2026.
- Verdence Capital Advisors sold 275 CVS Health shares in Q2 2026, an estimated $24.5K.
- CVS Health made up 0.04% of Verdence Capital Advisors's portfolio in Q2 2026, its #354 holding.
- Verdence Capital Advisors first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
- Verdence Capital Advisors's CVS Health position peaked at $1.24M in Q4 2022.
- 997 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.